Factors related to prehospital time delay in acute ST-segment elevation myocardial infarction

Yong Hwan Park1, Gu Hyun Kang, Bong Gun Song

  • 1Division of Cardiology, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.

Insights

Prehospital delay in ST-segment elevation myocardial infarction (STEMI) patients is linked to lower education, nighttime onset, and private transport. This delay increases in-hospital mortality risk, highlighting areas for intervention.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Door-to-balloon time in ST-segment elevation myocardial infarction (STEMI) has improved, but prehospital delay remains a significant challenge.
  • Factors contributing to prehospital delay in Korea are not well-defined, impacting timely treatment for acute myocardial infarction.

Purpose of the Study:

  • To identify sociodemographic and clinical factors associated with prehospital delay in STEMI patients in Korea.
  • To investigate the impact of prehospital delay on inhospital mortality.

Main Methods:

  • Retrospective analysis of 423 STEMI patients.
  • Patients categorized into short (≤180 min) and long (>180 min) prehospital delay groups based on symptom onset-to-door time.
  • Multivariate analysis to identify independent predictors of prehospital delay.

Main Results:

  • Mean symptom onset-to-door time was 255 minutes; long delay was associated with significantly higher inhospital mortality (6.9% vs 2.8%).
  • Factors significantly associated with long prehospital delay included low educational level, nighttime symptom onset, triage via another hospital, and private transport.
  • Multivariate analysis confirmed low education, nighttime onset, triage via another hospital, and private transport as significant predictors of prehospital delay.

Conclusions:

  • Prehospital delay in STEMI is influenced by socioeconomic factors (low education), time of onset (nighttime), healthcare access (triage via other hospital), and transport method (private transport).
  • Addressing these factors is crucial for reducing prehospital delay and improving outcomes for STEMI patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...